Last $15.35 USD
Change Today +0.08 / 0.52%
Volume 544.7K
DEPO On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carl A. Pelzel

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

63--

Background*

Mr. Carl A. Pelzel served as the President and Chief Executive Officer of DepoMed Inc. since August 27, 2007 and also served as its Executive Vice President and Chief Operating Officer since September 27, 2005. Mr. Pelzel served as Vice President - Marketing and Commercial Development of Depomed Inc. since June 16, 2005. Mr. Pelzel, a proven biotechnology and pharmaceutical Executive, has over 28 years of experience in discovery, development and global commercialization ...

Read Full Background

Corporate Headquarters*

7999 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-744-8000
Fax: 510-744-8001

Board Members Memberships*

Director, President and Chief Executive Officer
2007-N/A
Former Chief Executive Officer, President and Director

Education*

Bachelor's Degree
Hartwick College
BA
Hartwick College
MS
Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DEPO:US $15.35 USD +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Indra K. Nooyi M.P.P.M.Chairman and Chief Executive Officer
Pepsico, Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEPOMED INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.